Review decisions
Showing 740 results of 1550 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00792
Product Type: Drug
Control Number: 237685
Manufacturer: Allergan Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-27
Decision / Authorization Date: 2021-03-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00851
Product Type: Drug
Control Number: 237814
DIN(s): 02513447
Manufacturer: Amgen Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-03-30
Decision / Authorization Date: 2021-03-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00868
Product Type: Drug
Control Number: 234460
Manufacturer: Ferrer Internacional, S.A.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-12-13
Decision / Authorization Date: 2021-03-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00779
Product Type: Drug
Control Number: 246758
DIN(s): 02513153
Manufacturer: Janssen Inc.
Submission Type: Application filed under section 3 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2020-11-30
Decision / Authorization Date: 2021-03-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00829
Product Type: Drug
Control Number: 237680
DIN(s): 02479206, 02479214, 02479222, 02479230
Manufacturer: Takeda Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-27
Decision / Authorization Date: 2021-03-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01016
Product Type: Drug
Control Number: 240864
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-06-19
Decision / Authorization Date: 2021-03-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01016
Product Type: Drug
Control Number: 240864
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-06-19
Decision / Authorization Date: 2021-03-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00783
Product Type: Drug
Control Number: 237371
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2020-03-20
Decision / Authorization Date: 2021-03-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00780
Product Type: Drug
Control Number: 237402
DIN(s): 02512912, 02512920
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2020-03-20
Decision / Authorization Date: 2021-03-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00772
Product Type: Drug
Control Number: 244627
DIN(s): 02510847, 02511444
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Application filed under section 3 of the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
Date Filed / Submission Date: 2020-10-01
Decision / Authorization Date: 2021-02-26